Crispr Therapeutics shares owned by 180 Wealth Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by 180 Wealth Advisors
from 13F filings
Historical chart of 180 Wealth Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by 180 Wealth Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by 180 Wealth Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $450k | 6.9k | 64.81 |
| 2025-06-30 | $357k | 7.3k | 48.64 |
| 2025-03-31 | $216k | 6.3k | 34.03 |
| 2024-12-31 | $203k | 5.2k | 39.36 |
| 2024-09-30 | $205k | 4.4k | 46.98 |
| 2024-06-30 | $210k | 3.7k | 56.81 |
| 2022-09-30 | $201k | 3.1k | 65.41 |